{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T09:27:46Z","timestamp":1794302866461,"version":"4.9.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ajo.2026.08.023","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T23:34:03Z","timestamp":1787268843000},"page":"175-185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Describing Candidate Geographic Atrophy Phenotypes and Their Different Growth Parameters"],"prefix":"10.1016","volume":"292","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7289-1509","authenticated-orcid":false,"given":"Talisa E.","family":"de Carlo Forest","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc T.","family":"Mathias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Grove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5746-6854","authenticated-orcid":false,"given":"Niranjan","family":"Manoharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Cordaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2223-6888","authenticated-orcid":false,"given":"Aaron D.","family":"Beckwith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4766-6278","authenticated-orcid":false,"given":"Giacomo","family":"Nebbia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5028-6919","authenticated-orcid":false,"given":"Stephen M.","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayashree","family":"Kalpathy-Cramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6508-8136","authenticated-orcid":false,"given":"Anne M.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naresh","family":"Mandava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajo.2026.08.023_bib0001","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41572-021-00265-2","article-title":"Age-related macular degeneration","volume":"7","author":"Fleckenstein","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"10.1016\/j.ajo.2026.08.023_bib0002","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ophtha.2017.08.038","article-title":"The progression of geographic atrophy secondary to age-related macular degeneration","volume":"125","author":"Fleckenstein","year":"2018","journal-title":"Ophthalmology"},{"issue":"10411","key":"10.1016\/j.ajo.2026.08.023_bib0003","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/S0140-6736(23)01520-9","article-title":"Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials","volume":"402","author":"Heier","year":"2023","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ajo.2026.08.023_bib0004","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ophtha.2020.08.027","article-title":"C5 inhibitor avacincaptad pegol for geographic atrophy due to age-related macular degeneration: a randomized pivotal phase 2\/3 trial","volume":"128","author":"Jaffe","year":"2021","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ajo.2026.08.023_bib0005","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3928\/23258160-20250217-01","article-title":"Pegcetacoplan for geographic atrophy over 30 months: data from OAKS, DERBY, and the GALE long-term extension study","volume":"56","author":"Goldberg","year":"2025","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.ajo.2026.08.023_bib0006","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ajo.2025.09.006","article-title":"Real-world experience with intravitreal pegcetacoplan for the treatment of geographic atrophy in age-related macular degeneration","volume":"281","author":"Shen","year":"2025","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2026.08.023_bib0007","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.2147\/OPTH.S518398","article-title":"Real-world outcomes with complement inhibitors for geographic atrophy: a comparative study of pegacetacoplan versus avacincaptad pegol","volume":"19","author":"Rush","year":"2025","journal-title":"Clin Ophthalmol"},{"issue":"14","key":"10.1016\/j.ajo.2026.08.023_bib0008","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1080\/1750743X.2025.2569302","article-title":"Plain language summary of disease activity and therapeutic response to pegcetacoplan for geographic atrophy identified by deep learning-based analysis of OCT","volume":"17","author":"Schmidt-Erfurth","year":"2025","journal-title":"Immunotherapy"},{"issue":"7","key":"10.1016\/j.ajo.2026.08.023_bib0009","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1097\/IAE.0000000000003796","article-title":"Complement inhibition for geographic atrophy: Review of salient functional outcomes and perspective","volume":"43","author":"Spaide","year":"2023","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2026.08.023_bib0010","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ajo.2024.02.021","article-title":"Drug approval for the treatment of geographic atrophy: how we got here and where we need to go","volume":"263","author":"Csaky","year":"2024","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2026.08.023_bib0011","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1177\/24741264251367100","article-title":"Real-world experience of geographic atrophy treatment with avacincaptad pegol","volume":"9","author":"Abou-Samra","year":"2025","journal-title":"J Vitreoretin Dis"},{"key":"10.1016\/j.ajo.2026.08.023_bib0012","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ajo.2025.04.022","article-title":"Ocular adverse events associated with pegcetacoplan and avacincaptad pegol for geographic atrophy: a population-based pharmacovigilance study","volume":"276","author":"Kailani","year":"2025","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2026.08.023_bib0013","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/jamaophthalmol.2018.1544","article-title":"Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: chroma and Spectri phase 3 randomized clinical trials","volume":"136","author":"Holz","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ajo.2026.08.023_bib0014","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ajo.2025.03.021","article-title":"Phase 2 study of the anti-high temperature requirement A1 (HtrA1) fab galegenimab (FHTR2163) in geographic atrophy secondary to age-related macular degeneration","volume":"275","author":"Eichenbaum","year":"2025","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2026.08.023_bib0015","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1080\/13543784.2022.2113375","article-title":"Investigational drugs in clinical trials for macular degeneration","volume":"31","author":"Tolentino","year":"2022","journal-title":"Expert Opin Investig Drugs"},{"issue":"3","key":"10.1016\/j.ajo.2026.08.023_bib0016","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41433-022-02115-1","article-title":"Perspectives from clinical trials: is geographic atrophy one disease?","volume":"37","author":"Sivaprasad","year":"2023","journal-title":"Eye (Lond)"},{"issue":"5","key":"10.1016\/j.ajo.2026.08.023_bib0017","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.ophtha.2016.01.034","article-title":"Anatomic clinical trial endpoints for nonexudative age-related macular degeneration","volume":"123","author":"Schaal","year":"2016","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ajo.2026.08.023_bib0018","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/jamaophthalmol.2019.1318","article-title":"Assessment of novel genome-wide significant gene loci and lesion growth in geographic atrophy secondary to age-related macular degeneration","volume":"137","author":"Grassmann","year":"2019","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2026.08.023_bib0019","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1001\/jamaophthalmol.2013.8175","article-title":"Growth of geographic atrophy on fundus autofluorescence and polymorphisms of CFH, CFB, C3, FHR1-3, and ARMS2 in age-related macular degeneration","volume":"132","author":"Caire","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2026.08.023_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007418","article-title":"CFH, C3 and ARMS2 are significant risk loci for susceptibility but not for disease progression of geographic atrophy due to AMD","volume":"4","author":"Scholl","year":"2009","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ajo.2026.08.023_bib0021","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ophtha.2023.09.013","article-title":"Critical dependence on area in relationship between ARMS2\/HTRA1 genotype and faster geographic atrophy enlargement: age-related eye disease study 2 report number 33","volume":"131","author":"Agr\u00f3n","year":"2024","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ajo.2026.08.023_bib0022","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1001\/jamaophthalmol.2021.4601","article-title":"Association of smoking, alcohol consumption, blood pressure, body mass index, and glycemic risk factors with age-related macular degeneration: a mendelian randomization study","volume":"139","author":"Kuan","year":"2021","journal-title":"JAMA Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2026.08.023_bib0023","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.ophtha.2018.05.028","article-title":"Progression of geographic atrophy in age-related macular degeneration: AREDS2 report number 16","volume":"125","author":"Keenan","year":"2018","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ajo.2026.08.023_bib0024","article-title":"Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration","volume":"9","author":"Evans","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.ajo.2026.08.023_bib0025","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.oret.2024.11.006","article-title":"Alcohol consumption and risk of age-related macular degeneration and geographic atrophy progression: age-related eye diseases study 2 report 34","volume":"9","author":"Duic","year":"2025","journal-title":"Ophthalmol Retina"},{"issue":"7","key":"10.1016\/j.ajo.2026.08.023_bib0026","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/bjo.2004.057794","article-title":"Classification of abnormal fundus autofluorescence patterns in the junctional zone of geographic atrophy in patients with age related macular degeneration","volume":"89","author":"Bindewald","year":"2005","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2026.08.023_bib0027","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ajo.2006.11.041","article-title":"Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration","volume":"143","author":"Holz","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2026.08.023_bib0028","doi-asserted-by":"crossref","first-page":"e204","DOI":"10.1111\/aos.17431","article-title":"Photoreceptor-RPE loss ratio and fundus autofluorescence patterns as predictive factors for lesion progression in geographic atrophy","volume":"103","author":"Egger","year":"2025","journal-title":"Acta Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2026.08.023_bib0029","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1097\/IAE.0000000000002480","article-title":"Reclassification of fundus autofluorescence patterns surrounding geographic atrophy based on progression rate: a systematic review and meta-analysis","volume":"39","author":"Shen","year":"2019","journal-title":"Retina"},{"issue":"5","key":"10.1016\/j.ajo.2026.08.023_bib0030","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3390\/jimaging10050116","article-title":"When two eyes don\u2019t suffice-learning difficult hyperfluorescence segmentations in retinal fundus autofluorescence images via Ensemble Learning","volume":"10","author":"Santarossa","year":"2024","journal-title":"J Imaging"},{"issue":"3","key":"10.1016\/j.ajo.2026.08.023_bib0031","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.oret.2022.08.018","article-title":"Deep learning to predict geographic atrophy area and growth rate from multimodal imaging","volume":"7","author":"Anegondi","year":"2023","journal-title":"Ophthalmol Retina"},{"issue":"8","key":"10.1016\/j.ajo.2026.08.023_bib0032","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.ophtha.2016.04.042","article-title":"Fully automated prediction of geographic atrophy growth using quantitative spectral-domain optical coherence tomography biomarkers","volume":"123","author":"Niu","year":"2016","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ajo.2026.08.023_bib0033","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1167\/tvst.10.7.26","article-title":"Growth modeling for quantitative, spatially resolved geographic atrophy lesion kinetics","volume":"10","author":"Moult","year":"2021","journal-title":"Transl Vis Sci Technol"},{"issue":"7","key":"10.1016\/j.ajo.2026.08.023_bib0034","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1364\/BOE.427819","article-title":"Analysis of correlations between local geographic atrophy growth rates and local OCT angiography-measured choriocapillaris flow deficits","volume":"12","author":"Moult","year":"2021","journal-title":"Biomed Opt Express"},{"key":"10.1016\/j.ajo.2026.08.023_bib0035","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ajo.2021.10.032","article-title":"Optical coherence tomography measurements of the retinal pigment epithelium to Bruch membrane thickness around geographic atrophy correlate with growth","volume":"236","author":"Chu","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2026.08.023_bib0036","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ajo.2024.03.023","article-title":"Association between quantitative and qualitative imaging biomarkers and geographic atrophy growth rate","volume":"264","author":"de Carlo Forest","year":"2024","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2026.08.023_bib0037","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s00417-022-05931-z","article-title":"Future perspectives for treating patients with geographic atrophy","volume":"261","author":"Loewenstein","year":"2023","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2026.08.023_bib0038","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.oret.2022.12.013","article-title":"Geographic atrophy phenotypes in subjects of different ethnicity: Asia-Pacific Ocular Imaging Society Work Group Report 3","volume":"7","author":"Teo","year":"2023","journal-title":"Ophthalmol Retina"},{"issue":"1","key":"10.1016\/j.ajo.2026.08.023_bib0039","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2024-002105","article-title":"Consideration of patient phenotypes in geographic atrophy due to age-related macular degeneration","volume":"10","author":"Singh","year":"2025","journal-title":"BMJ Open Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2026.08.023_bib0040","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/bjophthalmol-2017-310268","article-title":"Geographic atrophy phenotype identification by cluster analysis","volume":"102","author":"Mon\u00e9s","year":"2018","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2026.08.023_bib0041","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.oret.2020.04.014","article-title":"Genotype- and phenotype-based subgroups in geographic atrophy secondary to age-related macular degeneration: the EYE-RISK consortium","volume":"4","author":"Biarn\u00e9s","year":"2020","journal-title":"Ophthalmol Retina"},{"issue":"5","key":"10.1016\/j.ajo.2026.08.023_bib0042","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ophtha.2022.11.026","article-title":"Reticular pseudodrusen status, ARMS2\/HTRA1 genotype, and geographic atrophy enlargement: age-related eye disease study 2 report 32","volume":"130","author":"Agr\u00f3n","year":"2023","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2026.08.023_bib0043","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.oret.2022.08.003","article-title":"Predicting topographic disease progression and treatment response of pegcetacoplan in geographic atrophy quantified by deep learning","volume":"7","author":"Vogl","year":"2023","journal-title":"Ophthalmol Retina"},{"issue":"9","key":"10.1016\/j.ajo.2026.08.023_bib0044","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.oret.2020.03.020","article-title":"Progression of unifocal versus multifocal geographic atrophy in age-related macular degeneration: a systematic review and meta-analysis","volume":"4","author":"Shen","year":"2020","journal-title":"Ophthalmol Retina"},{"issue":"12","key":"10.1016\/j.ajo.2026.08.023_bib0045","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1016\/j.ophtha.2013.07.047","article-title":"Circularity index as a risk factor for progression of geographic atrophy","volume":"120","author":"Domalpally","year":"2013","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ajo.2026.08.023_bib0046","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/S0161-6420(99)90340-8","article-title":"Enlargement of atrophy and visual acuity loss in the geographic atrophy form of age-related macular degeneration","volume":"106","author":"Sunness","year":"1999","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ajo.2026.08.023_bib0047","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.oret.2020.12.002","article-title":"Geographic atrophy growth is strongly related to lesion perimeter: unifying effects of lesion area, number, and circularity on growth","volume":"5","author":"Shen","year":"2021","journal-title":"Ophthalmol Retina"},{"issue":"4","key":"10.1016\/j.ajo.2026.08.023_bib0048","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/IAE.0000000000002023","article-title":"Colorado age-related macular degeneration registry: design and clinical risk factors of the cohort","volume":"39","author":"Lynch","year":"2019","journal-title":"Retina"},{"issue":"8","key":"10.1016\/j.ajo.2026.08.023_bib0049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1167\/tvst.12.8.1","article-title":"Interleukin-4 plasma levels stratified by sex in intermediate age-related macular degeneration and geographic atrophy","volume":"12","author":"Rajeswaren","year":"2023","journal-title":"Transl Vis Sci Technol"},{"issue":"4","key":"10.1016\/j.ajo.2026.08.023_bib0050","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ophtha.2012.10.036","article-title":"Clinical classification of age-related macular degeneration","volume":"120","author":"Ferris","year":"2013","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2026.08.023_bib0051","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ophtha.2017.09.028","article-title":"Consensus definition for atrophy associated with age-related macular degeneration on OCT: classification of Atrophy Report 3","volume":"125","author":"Sadda","year":"2018","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2026.08.023_bib0052","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1167\/tvst.11.5.22","article-title":"Sex and age-related differences in complement factors among patients with intermediate age-related macular degeneration","volume":"11","author":"Marin","year":"2022","journal-title":"Transl Vis Sci Technol"},{"issue":"1","key":"10.1016\/j.ajo.2026.08.023_bib0053","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41467-024-44824-z","article-title":"Segment anything in medical images","volume":"15","author":"Ma","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajo.2026.08.023_bib0054","article-title":"Patient-level forecasting of geographic atrophy with a biologically grounded Gompertz model","author":"Beckwith","year":"2025","journal-title":"medRxiv"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426004757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426004757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T09:06:07Z","timestamp":1794301567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939426004757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":54,"alternative-id":["S0002939426004757"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2026.08.023","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Describing Candidate Geographic Atrophy Phenotypes and Their Different Growth Parameters","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2026.08.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}